My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking

Result Updates | Jul 22nd 2016

ITC Ltd

CMP : 250Target Price : 283

ITC posted a healthy set of numbers for 1QFY2017, both on the top-line and the bottom-line front. The top-line was strong due to healthy growth in Cigarettes, other FMCG & Agri businesses which resulted in a higher overall profitability of the company. Key highlights: ITC’s net sales for the quarter grew by 9.8% yoy to Rs10,054cr. In ..

View As PDF

Result Updates | Jul 21st 2016

Tata Consultancy Services Ltd

CMP : 2,493Target Price : 2,867

TCS posted a 3.7% sequential growth in USD revenues to US$4,362mn for 1QFY2017 (V/s US$4,375mn expected), which was mostly volume led (3.4% qoq growth). On constant currency (CC) basis, the revenue growth is of 3.1% qoq. On the operating front, the EBITDA and EBIT margins came in at 26.7% and 25.1%, a dip of ~97bp and ~98bp qoq respective..

View As PDF

Sort By

Result Updates | Jul 20th 2016

Hindustan Unilever Ltd

CMP : 895
Target Price :

Hindustan Unilever (HUL)’s performance for 1QFY2017 was slightly below consensus expectations. For the quarter, the company’s top-line grew by 3.6% yoy to `8,128cr while the reported PAT grew ~10% yoy to `1,174cr. Key highlights: For 1QFY2017, HUL’s overall top-line rose by 3.6% yoy to `8,128cr on the back of 4% volume growth. The Soaps &..

Result Updates | Jul 20th 2016

Infosys Ltd

CMP : 1,082
Target Price : 1,370

Infosys’ numbers for 1QFY2017 have come in lower than our expectations. Its revenues grew 2.2% on a sequential basis to US$2,501mn (V/s US$2,548mn expected); the growth was mostly volume led. In INR terms, revenues came in at `16,782cr (V/s `17,072cr expected), up 1.4% qoq. In constant currency (CC) terms, sales grew 1.7% qoq. On the oper..

Initiating Coverage | Jun 20th 2016

Equitas Holdings Ltd

CMP : 174
Target Price : 235

Equitas Holdings is one of the fastest growing microfinance institutions in India having a wide portfolio of product. Backed by strong Management and recently procured license for setting up a small finance bank (SFB), it is all set for its next leg of growth. Post its conversion into a SFB, Equitas intends to continue to focus on high yi..

Result Updates | Jun 17th 2016

Indoco Remedies Ltd

CMP : 282
Target Price : 225

Indoco Remedies (Indoco) results for 4QFY2016 have come in much below our expectations. The company posted a 20.5% yoy growth in sales to Rs255cr, although the same is lower than our expectation of Rs300cr. The growth was mainly driven by exports (Rs117.8cr), which grew by 43.8% yoy, while domestic sales (Rs136.3cr) rose 5.6% yoy. On the ..

Result Updates | Jun 14th 2016

Ipca Laboratories Ltd

CMP : 431
Target Price : 613

IPCA Laboratories (Ipca)’s results for 4QFY2016 have come in much lower than our expectations on the sales and the operating front, while a tax write-back led the net profit to outperform our estimates. Sales for the quarter de-grew 1.7% yoy to Rs612cr (V/s Rs680cr expected). On the operating front, the gross margin came in at 64.4% V/s 5..

Result Updates | Jun 14th 2016

Aurobindo Pharma Ltd

CMP : 773
Target Price : 850

Aurobindo Pharma (APL)’s results for 4QFY2016 have come in marginally lower than our expectations. Sales grew by 16.9% yoy to Rs3,675cr (vs Rs3,800cr expected), driven by formulations (which grew by 34.6% yoy; constitute ~79.5% of sales). The key geographies in terms of formulations - US, Europe & ROW- and the ARV segment posted a yoy..

Company Updates | Jun 10th 2016

Goodyear India Ltd

CMP : 515
Target Price : 631

Expectation of normal monsoon to energize stagnant tractor demand: Goodyear India (GIL) is a leader in the farm tyre segment in India with it having strong tieups with OEMs as well as a dominant presence in the replacement market. Farm tyres account for ~50% of the company’s overall revenues; however, the segment has been under pressure o..

Result Updates | Jun 10th 2016

Cipla Ltd

CMP : 469
Target Price :

Cipla’s results for 4QFY2016 have come much below our expectations. Sales came in at Rs3,207cr V/s Rs3,274cr expected, a yoy growth of 7.6%. The sales growth was driven by domestic formulations (Rs1,258cr), as expected, which grew 15.9% yoy, while exports posted a yoy growth of 7.4%. On the operating front, the EBDITA came in at 5.0% V/s ..

Result Updates | Jun 10th 2016

Sun Pharmaceuticals Industries Ltd

CMP : 739
Target Price : 944

For 4QFY2016, Sun Pharmaceuticals Industries (Sun Pharma) posted results marginally lower than our expectations. Sales for the quarter, at Rs7,414cr (V/s Rs7,700cr estimated) grew 20.7% yoy. On the operating front, the company posted an OPM of 31.0% V/s 14.3% in 4QFY2015 and V/s our expectation of 34.9%. Thus, the net profit came in at Rs..

Result Updates | Jun 10th 2016

Glaxosmithkline Pharma Ltd

CMP : 3,515
Target Price :

For 4QFY2016, GlaxoSmithKline Pharmaceuticals (GSK)’s sales rose by Rs686cr, up 11.8% yoy. On the operating front, the gross margin and the EBITDA margin came in at 55.0% and 17.8% respectively V/s 57.1% and 19.4% during the corresponding period of the previous year. The reported net profit for the quarter thus came in at Rs106cr V/s Rs10..